A new type of immunotherapy has shown promising preclinical results against a bone cancer called osteosarcoma, as part of a study in mice. A new type of immunotherapy, developed by UCL researchers, ...
Researchers from UC Davis and Lawrence Livermore National Laboratory developed and studied a new material — engineered bone marrow, or eBM. Engineered bone marrow offers a better way to study ...
Finding an effective treatment for osteosarcoma, the most common type of bone cancer in children and young adults, has puzzled medical researchers for 40 years. Now, a new study by researchers at Case ...
Finding an effective treatment for osteosarcoma, the most common type of bone cancer in children and young adults, has puzzled medical researchers for 40 years. Now, a new study by researchers at Case ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results